Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

Ted Koppel and his wife, Grace Anne Dorney Koppel — who was told she only had a few years left to live after her 2001 COPD ...

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses the potential of tailored treatment strategies and the importance of smoking cessation.

A recent study found that the respiratory and non-respiratory symptom burden in patients with COPD is high when compared with ...

Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms ...

In the United States, more than 10 million people above the age of 40 live with chronic obstructive pulmonary disease (COPD), a chronic lung disease that limits air flow and causes ...

The global airway disease treatment market is projected to experience significant growth over the next decade, with revenue ...

Analysts expect the partners’ first-mover advantage, clinical data and existing presence in lung disease to translate into ...

Treatment with Ohtuvayre in COPD was linked to improved lung function and other benefits across key patient subgroups in ...